Ankylosing Spondylitis News

December 3, 2020December 3, 2020

What My Nightly Struggle With Invisible Illness Looked Like

Ankylosing Spondylitis News

At 3:30 a.m., I sat in bed gasping for air with acute pain in my chest. Like every other night, I had gone to bed at 10 p.m. after completing ... Read more

November 19, 2020November 19, 2020

Just Keep Swimming

Ankylosing Spondylitis News

Have you ever watched the movie “Finding Nemo?” If you have, you might recall the scene in which Dory, the optimistic, forgetful, and friendly fish, tells her newfound fish friend ... Read more

November 16, 2020November 16, 2020

Clinical Trial Data Show Durable Efficacy of Cimzia, Bimekizumab

Ankylosing Spondylitis News

Treatment with Cimzia (certolizumab pegol) can ease eye inflammation in people with ankylosing spondylitis (AS), and reduce symptoms in those with active non-radiographic axial spondyloarthritis (nr-axSpA), new clinical trial data show. ... Read more

November 9, 2020November 9, 2020

Xeljanz Eases AS Symptoms in Phase 3 Trial

Ankylosing Spondylitis News

Treatment with Xeljanz (tofacitinib) was found to significantly ease symptoms of ankylosing spondylitis (AS) in a Phase 3 clinical trial. The results are being presented today at ACR Convergence 2020, ... Read more

November 2, 2020November 2, 2020

Gilead Suspends Enrollment in Phase 3 Trials of Filgotinib in AS

Ankylosing Spondylitis News

Gilead Sciences has suspended enrollment in two Phase 3 trials studying the effects of filgotinib, an anti-inflammatory therapy currently being investigated in several inflammatory conditions, in patients with ankylosing spondylitis ... Read more

October 28, 2020November 30, 2020

UK Organization ‘Same But Different’ Announces ‘Glimmer of Hope’ Photo Contest Winner

Ankylosing Spondylitis News

A photo of a bespectacled young boy, his red baseball cap slightly askew as he  enjoys time outside, will be featured on the front cover of an upcoming calendar in ... Read more

October 26, 2020October 26, 2020

Humira Boosts Work Productivity, Lessens Sleep Problems in AS, Study Finds

Ankylosing Spondylitis News

Treatment with Humira (adalimumab) increases work productivity, reduces sleep problems, and eases disease activity in people with ankylosing spondylitis (AS) and related diseases, a new real-world study indicates. The study, ... Read more

October 19, 2020October 19, 2020

COVID-19 Lockdown Led to Fewer Swiss Patients Adhering to Treatment With Little Impact on Disease Activity

Ankylosing Spondylitis News, COVID-19 News

A short interruption in in-person medical visits due to the COVID-19 pandemic significantly decreased treatment adherence but had little impact on disease activity in people with axial spondyloarthritis (axSpA), according to ... Read more

October 12, 2020October 12, 2020

AS Pain Linked With Depression, Anxiety, Stress, Study Finds

Ankylosing Spondylitis News

People with ankylosing spondylitis (AS) often endure considerable psychological distress — including depression, anxiety, and stress — that is related to their experience of pain, a study shows. These findings ... Read more

October 6, 2020November 6, 2020

Same But Different Asks Public to Vote on ‘Glimmer of Hope’ Calendar Photos

Ankylosing Spondylitis News, COVID-19 News

Same But Different, a nonprofit U.K. group that uses art for social change, is inviting people to choose their favorite photographs in a calendar contest to heighten awareness of rare diseases, ... Read more

September 30, 2020September 30, 2020

Ankylosing Spondylitis Is Not Your Fault

Ankylosing Spondylitis News

Some people just don’t “get” chronic illness, and they can be pretty cruel about it — or thoughtless, at the very least. It’s hard when people don’t understand what it’s ... Read more

September 28, 2020September 28, 2020

Study Supports Efficacy of Cosentyx for Patients in China, Other Countries

Ankylosing Spondylitis News

Cosentyx (secukinumab) is a safe and effective treatment for ankylosing spondylitis (AS), producing similar results in Chinese patients compared to other populations, a Phase 3 study indicates. The study, “Secukinumab ... Read more

September 21, 2020September 22, 2020

Obesity Increases Risk of Worse Overall Health in AS

Ankylosing Spondylitis News

Obesity is a risk factor for worse overall health in people with ankylosing spondylitis (AS), and is associated with increased inflammation, disease activity, and cardiovascular risk, a Taiwanese study has ... Read more

September 14, 2020September 15, 2020

Cosentyx Effective in Active nr-axSpA, Phase 3 PREVENT Trial Shows

Ankylosing Spondylitis News

Treatment with Cosentyx (secukinumab) leads to sustained reductions in symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) over one year, according to the Phase 3 PREVENT trial. These findings were the ... Read more

August 31, 2020August 31, 2020

AbbVie Seeks FDA, EMA Approvals of Rinvoq for Active AS

Ankylosing Spondylitis News

AbbVie has submitted an application to the U.S. Food and Drug Administration (FDA) requesting the approval of Rinvoq (upadacitinib) for the treatment of adults with active ankylosing spondylitis (AS). A ... Read more